BAY-598

CAS No. 1906919-67-2

BAY-598( —— )

Catalog No. M20776 CAS No. 1906919-67-2

BAY-598 is a selective inhibitor of SMYD2 with IC50 values of 27 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 93 In Stock
5MG 84 In Stock
10MG 135 In Stock
25MG 250 In Stock
50MG 398 In Stock
100MG 600 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BAY-598
  • Note
    Research use only, not for human use.
  • Brief Description
    BAY-598 is a selective inhibitor of SMYD2 with IC50 values of 27 nM.
  • Description
    BAY-598 is a selective inhibitor of SMYD2 with IC50 values of 27 nM.
  • In Vitro
    BAY-598 treatment blocks in vitro methylation of MAPKAPK3 by SMYD2 but has no activity against the SMYD2-related KMT SMYD3. BAY-598 treatment reduces the growth of Kras;p53 mutant PDAC cells after 9 d in culture but has little impact on the growth of Kras;p53;Smyd2 mutant cells.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    SMYD2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1906919-67-2
  • Formula Weight
    525.34
  • Molecular Formula
    C22H20Cl2F2N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (237.94 mM)
  • SMILES
    CCN(C(=O)CO)C1CN(C(=Nc2cccc(OC(F)F)c2)NC#N)N=C1c1ccc(Cl)c(Cl)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Reynoird N Mazur P K Stellfeld T et al. Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer[J]. Genes & Development 2016:genesdev;gad.275529.115v1.
molnova catalog
related products
  • KDM5A covalent inhib...

    KDM5A covalent inhibitor N73 is the the isopropyl ester derivative of N71.

  • P3FI-63

    P3FI-63 is a selective KDM3B inhibitor (IC50: 7 μM) with antitumor activity for the study of fusion-positive rhabdomyosarcoma and other transcriptionally addictive cancers.

  • SD49-7

    SD49-7 is an inhibitor of histone lysine demethylase 4 (KDM4) with an IC50 of 0.19 μM.